RAPT Therapeutics, Inc.RAPTNASDAQ
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q3 2025 | 1.97% |
| Q2 2025 | -0.39% |
| Q1 2025 | -9.81% |
| Q4 2024 | 24.21% |
| Q3 2024 | -3.62% |
| Q2 2024 | -9.87% |
| Q1 2024 | 15.03% |
| Q4 2023 | -6.44% |
| Q3 2023 | 2.60% |
| Q2 2023 | 12.26% |
| Q1 2023 | 20.31% |
| Q4 2022 | -2.01% |
| Q3 2022 | -6.57% |
| Q2 2022 | 14.49% |
| Q1 2022 | 5.72% |
| Q4 2021 | 19.00% |
| Q3 2021 | 0.37% |
| Q2 2021 | -6.28% |
| Q1 2021 | 15.19% |
| Q4 2020 | 8.95% |
| Q3 2020 | 14.10% |
| Q2 2020 | -14.81% |
| Q1 2020 | 25.30% |
| Q4 2019 | 51.47% |
| Q3 2019 | -35.62% |
| Q2 2019 | 60.81% |
| Q1 2019 | 29.67% |
| Q4 2018 | -5.35% |
| Q3 2018 | -7.08% |
| Q2 2018 | 38.88% |
| Q1 2018 | 0.00% |